Apostolos Gkazepis

Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1

N. Brünner, J. Foekens, N. Harbeck, 2010, Expert review of molecular diagnostics.

Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer.

A. Scorilas, E. Diamandis, M. Kiechle, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients' survival.

V. Magdolen, P. Sedlaczek, A. Harłozińska, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer

M. Wirth, M. Schmitt, M. Kotzsch, 2010, Biological chemistry.

Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects

N. Harbeck, M. Schmitt, V. Magdolen, 2008, Breast Care.

Identification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal regions: a validation study

P. Nederlof, A. Meindl, E. Gross, 2016, BMC Cancer.

Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues.

M. Schmitt, Wei-Jen Tang, M. Rosner, 2008, International journal of molecular medicine.

Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1

N. Brünner, J. Foekens, N. Harbeck, 2010, Expert review of molecular diagnostics.

Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers

A. Meindl, A. V. van Kuilenburg, E. Gross, 2013, British Journal of Cancer.

Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer.

E. Diamandis, M. Kiechle, M. Schmitt, 2014, Biological chemistry.

Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients

R. Langer, A. Walch, E. Diamandis, 2012, Biological chemistry.